Compare · CRWD vs PEAR
CRWD vs PEAR
Side-by-side comparison of CrowdStrike Holdings Inc. (CRWD) and Pear Therapeutics Inc. (PEAR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CRWD and PEAR operate in Computer Software: Prepackaged Software (Technology), so they compete in similar markets.
- CRWD is the larger of the two at $167.70B, about 312.9x PEAR ($536.0M).
- CRWD has hit the wire 42 times in the past 4 weeks while PEAR has been quiet.
- CRWD has more recent analyst coverage (25 ratings vs 6 for PEAR).
- Company
- CrowdStrike Holdings Inc.
- Pear Therapeutics Inc.
- Price
- $633.29-3.86%
- $0.03-36.03%
- Market cap
- $167.70B
- $536.0M
- 1M return
- +20.01%
- -
- 1Y return
- +36.42%
- -
- Industry
- Computer Software: Prepackaged Software
- Computer Software: Prepackaged Software
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2019
- 2021
- News (4w)
- 42
- 0
- Recent ratings
- 25
- 6
CrowdStrike Holdings Inc.
CrowdStrike Holdings, Inc. provides cloud-delivered solutions for endpoint and cloud workload protection in the United States, Australia, Germany, India, Israel, Romania, and the United Kingdom. It offers 19 cloud modules on its Falcon platform through a software as a service subscription-based model that covers various security markets, such as corporate workload security, security and vulnerability management, managed security services, IT operations management, threat intelligence services, identity protection, and log management. The company primarily sells its platform and cloud modules through its direct sales team. CrowdStrike Holdings, Inc. was incorporated in 2011 and is headquartered in Sunnyvale, California.
Pear Therapeutics Inc.
Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts.
Latest CRWD
- Seattle Sounders FC Selects CrowdStrike and Redapt to Strengthen Cyber Resilience Ahead of FIFA World Cup 2026
- CrowdStrike 2026 Technology Threat Landscape Report: China Steals AI Capabilities It Can't Build
- A Next-Gen Intelligence Platform Operating at the Intersection of AI, Defense Technology, and Quantum Cybersecurity
- PRESIDENT AND CEO Kurtz George sold $868,977 worth of shares (1,220 units at $712.28), decreasing direct ownership by 0.06% to 2,137,022 units (SEC Form 4)
- PRESIDENT AND CEO Kurtz George sold $2,760,328 worth of shares (3,780 units at $730.25), decreasing direct ownership by 0.18% to 2,138,242 units (SEC Form 4)
- SEC Form 144 filed by CrowdStrike Holdings Inc.
- SEC Form 144 filed by CrowdStrike Holdings Inc.
- CrowdStrike downgraded by Berenberg with a new price target
- BMO Capital Markets reiterated coverage on CrowdStrike with a new price target
- Needham reiterated coverage on CrowdStrike with a new price target
Latest PEAR
- SEC Form 25-NSE filed by Pear Therapeutics Inc.
- SEC Form SC 13D/A filed by Pear Therapeutics Inc. (Amendment)
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Stocks That Hit 52-Week Lows On Tuesday
- Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- Stocks That Hit 52-Week Lows On Monday
- 12 Health Care Stocks Moving In Monday's Intraday Session
- Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Why Marpai Shares Are Trading Lower By 26%; Here Are 20 Stocks Moving Premarket